You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 11, November 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Case Reports
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Aminoglycoside Macular Infarction in Association With Gentamicin-Soaked Collagen Corneal Shield

Eric D. Kanter, MD; Alexander J. Brucker, MD
Philadelphia, Pa

Arch Ophthalmol. 1995;113(11):1359-1360.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Presoaked collagen corneal shields are used as a means for the delivery of antibiotics to the corneal epithelium and stroma and the anterior chamber. We report a case of macular infarction that occurred in a patient after the placement of a gentamicin sulfate-impregnated collagen corneal shield following cataract surgery.

Report of a Case.

An 80-year-old man underwent extracapsular cataract extraction with phacoemulsification of the lens nucleus and implantation of a posterior chamber intraocular lens in the left eye. Preoperative visual acuity was 6/120 OS. Clinical evaluation demonstrated a visually significant cataract and mild atrophic retinal pigment epithelial changes. Visual acuity in the fellow eye was 6/12 with similar retinal pigment epithelial changes noted. A 5-mL peribulbar injection was performed with a 1.6-cm 27-gauge needle using equal amounts of 1% lidocaine hydrochloride (without epinephrine) and 0.5% bupivacaine hydrochloride and 0.5 mL (75 U) of hyaluronidase. Light digital massage of the globe . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.